Dissemin is shutting down on January 1st, 2025

Published in

Springer Nature [academic journals on nature.com], Genetics in Medicine, 1(11), p. 3-14

DOI: 10.1097/gim.0b013e318184137c

Human Genome Epidemiology, 2nd Edition, p. 458-481

DOI: 10.1093/acprof:oso/9780195398441.003.0023

Links

Tools

Export citation

Search in Google Scholar

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

Journal article published in 2009 by Steven M. Teutsch, Linda A. Bradley, Glenn E. Palomaki, James E. Haddow, Margaret Piper ORCID, Ned Calonge, W. David Dotson, Michael P. Douglas, Alfred O. Berg
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative, established by the National Office of Public Health Genomics at the Centers for Disease Control and Prevention, supports the development and implementation of a rigorous, evidence-based process for evaluating genetic tests and other genomic applications for clinical and public health practice in the United States. An independent, non-federal EGAPP Working Group (EWG), a multidisciplinary expert panel selects topics, oversees the systematic review of evidence, and makes recommendations based on that evidence. This article describes the EGAPP processes and details the specific methods and approaches used by the EWG.